Telomere‐based DNA damage responses: a new approach to melanoma

10.3322/canjclin.54.1.8

10.1038/nature00766

10.1097/00008390-199910000-00001

Pollock P. M., 2000, The genetics of cutaneous melanoma, Clin. Lab. Med., 20, 667

Zhang H., 2002, Expression of p16, p27, p53, p73 and Nup88 proteins in matched primary and metastatic melanoma cells, Int. J. Oncol., 21, 43

10.1073/pnas.0336397100

10.1097/00008390-199802000-00004

10.1074/jbc.M003670200

10.1016/S0960-9822(00)00781-8

10.1016/S0092-8674(00)81023-5

10.1126/science.281.5381.1317

10.1016/S0092-8674(00)80760-6

10.1126/science.283.5406.1321

10.1016/S0092-8674(00)80932-0

10.1126/science.1069523

10.1126/science.7544491

10.1126/science.275.5302.973

10.1126/science.277.5328.955

10.1146/annurev.bi.65.070196.002005

10.1126/science.7605428

10.1073/pnas.182407599

Villa R., 2000, Telomerase activity and telomere length in human ovarian cancer and melanoma cell lines: correlation with sensitivity to DNA damaging agents, Int. J. Oncol., 16, 995

10.1002/1097-0215(20001101)88:3<411::AID-IJC13>3.0.CO;2-P

10.1038/sj.neo.7900004

10.1038/sj.bjc.6690010

10.1007/s004030050387

Yang P., 2000, Telomerase activity and expression of apoptosis and anti‐apoptosis regulators in the progression pathway of human melanoma, Int. J. Oncol., 17, 913

10.1126/science.1076514

10.1084/jem.179.3.1005

Rivoltini L., 1995, Induction of tumor‐reactive CTL from peripheral blood and tumor‐infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART‐1, J. Immunol., 154, 2257, 10.4049/jimmunol.154.5.2257

10.1096/fj.02-0197com

10.1073/pnas.94.23.12627

10.1073/pnas.93.3.1087

10.1006/excr.2002.5531

10.1038/372413a0

10.1016/S0923-1811(00)00125-0

10.1016/S0921-8777(98)00071-8

10.1096/fj.01-0829fje

10.1073/pnas.0235444100

Byers H. R., 1993, Organ‐specific metastases in immuno‐deficient mice injected with human melanoma cells: a quantitative pathological analysis, Melanoma Res., 3, 247

Chen C., 1995, A strategy to discover circulating angiogenesis inhibitors generated by human tumors, Cancer Res., 55, 4230

10.1038/nm0298-232

10.1007/s002800050648

Byers H. R., 1991, Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time‐lapse and image analysis, Am. J. Pathol., 139, 423

10.1111/1523-1747.ep12264638

10.1046/j.1523-1747.1998.00324.x

Li J., 2001, Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins, Endocrinology, 142, 370, 10.1210/endo.142.1.7897

Sasaki H., 2000, Down‐regulation of X‐linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells, Cancer Res., 60, 5659

10.1007/s002620050015

10.1046/j.0022-202x.2001.01667.x

10.1002/j.1460-2075.1996.tb00519.x

10.3109/08830189609061753

10.1126/science.298.5593.522

10.1124/jpet.102.037192

10.1038/21697

10.1038/sj.onc.1203878